Aug 24, 2010 | Laboratory News, Laboratory Pathology
Hefty purchase price sends message to pathologists and clinical laboratory executives For any pathologist still harboring doubts about the future of digital pathology, yesterday’s surprise news that Roche Holding AG (VTX:ROG.VX) will pay $100 million to acquire BioImagene, Inc., provides compelling evidence that the digital pathology marketplace is ready for prime time. Roche announced that it will pay $100 million to buy privately-held BioImagene of Sunnyvale, California. The purchase will be...
